Tumor-derived biomarkers predict efficacy of B7H3 antibody-drug conjugate treatment in metastatic prostate cancer modelsSupreet Agarwal, Kathleen Kelly, Joel Bowman et al.|Journal of Clinical Investigation|2023Cited by 33
Tumor-derived biomarkers beyond antigen expression enhance efficacy of CD276/B7H3 antibody-drug conjugate in metastatic prostate cancerSupreet Agarwal, Kathleen Kelly, Lei Fang et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 1